Journal of Oncology Pharmacy Practice, Ahead of Print.
Hypersensitivity reactions (HSRs) to oxaliplatin are common in patients undergoing long-term chemotherapy. Desensitization is often recommended following initial reactions but is resource-intensive and may delay treatment. This study aimed to evaluate the ...